搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
6 小时
Rhythm Pharmaceuticals: A Key Year Ahead
Discover the latest on Rhythm Pharmaceuticals, Inc. and its asset, imcivree, targeting rare obesity disorders and potential ...
PipelineReview.com
20 小时
Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor ...
SOUTH SAN FRANCISCO, CA, USA I 05, 2024 I Denali Therapeutics Inc. (Nasdaq: DNLI) today announced initiation of dosing in a global Phase 2a clinical ...
manilatimes
9 天
Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib ...
Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
10 天
Alector stock drops after Alzheimer’s drug fails in Phase II trial
"Alector stock drops after Alzheimer’s drug fails in Phase II trial" was originally created and published by Clinical Trials ...
BMJ
16 天
Acral and periorificial scaly erythematous plaques in a child
Zinc supplementation was started. Genetic testing done simultaneously showed compound heterozygous mutations in SLC39A4 in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈